Foglino R, Barbetti F, Morotti E, Castorani V, Rigamonti A, Frontino G
Front Genet. 2024; 15:1414451.
PMID: 38978877
PMC: 11228259.
DOI: 10.3389/fgene.2024.1414451.
Fourman L, Lima J, Simha V, Cappa M, Alyaarubi S, Montenegro Jr R
Front Endocrinol (Lausanne). 2024; 15:1383318.
PMID: 38952397
PMC: 11215967.
DOI: 10.3389/fendo.2024.1383318.
Alvarez-Payares J, Ribero D, Rodriguez L, Builes C, Prieto C, Arango C
Case Rep Med. 2022; 2022:4655804.
PMID: 36275943
PMC: 9586807.
DOI: 10.1155/2022/4655804.
Kanbour S, Yenokyan G, Snyder R, Abusamaan M, Mathioudakis N
Endocr Pract. 2022; 28(12):1232-1236.
PMID: 36183992
PMC: 10628779.
DOI: 10.1016/j.eprac.2022.09.005.
Mainieri F, Tagi V, Chiarelli F
Front Endocrinol (Lausanne). 2022; 13:879979.
PMID: 35600578
PMC: 9114741.
DOI: 10.3389/fendo.2022.879979.
A Low-Carbohydrate Diet Realizes Medication Withdrawal: A Possible Opportunity for Effective Glycemic Control.
Han Y, Cheng B, Guo Y, Wang Q, Yang N, Lin P
Front Endocrinol (Lausanne). 2021; 12:779636.
PMID: 34970224
PMC: 8713744.
DOI: 10.3389/fendo.2021.779636.
Searching for the Culprit: When Diabetic Ketoacidosis Presents With Insulin Autoantibodies.
Garcia-Avila S, Samuel A, Farooqi I, Manickam R, Ismail M, Khaddash S
AACE Clin Case Rep. 2021; 7(2):158-162.
PMID: 34095477
PMC: 8053616.
DOI: 10.1016/j.aace.2020.12.004.
Effect of a 90 g/day low-carbohydrate diet on glycaemic control, small, dense low-density lipoprotein and carotid intima-media thickness in type 2 diabetic patients: An 18-month randomised controlled trial.
Chen C, Huang W, Chen H, Chang C, Lee L, Chen H
PLoS One. 2020; 15(10):e0240158.
PMID: 33017456
PMC: 7535044.
DOI: 10.1371/journal.pone.0240158.
Disrupting insulin signaling in Schwann cells impairs myelination and induces a sensory neuropathy.
Hackett A, Strickland A, Milbrandt J
Glia. 2019; 68(5):963-978.
PMID: 31758725
PMC: 7067678.
DOI: 10.1002/glia.23755.
Thyroid Hormone Effects on Glucose Disposal in Patients With Insulin Receptor Mutations.
Kushchayeva Y, Startzell M, Cochran E, Auh S, Sekizkardes H, Soldin S
J Clin Endocrinol Metab. 2019; 105(3).
PMID: 31588494
PMC: 7093053.
DOI: 10.1210/clinem/dgz079.
Thyroid Abnormalities in Patients With Extreme Insulin Resistance Syndromes.
Kushchayeva Y, Kushchayev S, Startzell M, Cochran E, Auh S, Dai Y
J Clin Endocrinol Metab. 2019; 104(6):2216-2228.
PMID: 30657911
PMC: 6482021.
DOI: 10.1210/jc.2018-02289.
Update on Therapeutic Options in Lipodystrophy.
Akinci B, Meral R, Arioglu Oral E
Curr Diab Rep. 2018; 18(12):139.
PMID: 30370487
DOI: 10.1007/s11892-018-1100-7.
Insulin autoimmune syndrome: from diagnosis to clinical management.
Censi S, Mian C, Betterle C
Ann Transl Med. 2018; 6(17):335.
PMID: 30306074
PMC: 6174196.
DOI: 10.21037/atm.2018.07.32.
Mecasermin in Insulin Receptor-Related Severe Insulin Resistance Syndromes: Case Report and Review of the Literature.
Plamper M, Gohlke B, Schreiner F, Woelfle J
Int J Mol Sci. 2018; 19(5).
PMID: 29695048
PMC: 5983765.
DOI: 10.3390/ijms19051268.
Glimepiride treatment in a patient with type A insulin resistance syndrome due to a novel heterozygous missense mutation in the insulin receptor gene.
Huang Z, Liu J, Ng K, Wan X, Xu L, He X
J Diabetes Investig. 2018; 9(5):1075-1083.
PMID: 29469970
PMC: 6123050.
DOI: 10.1111/jdi.12824.
Translating U-500R Randomized Clinical Trial Evidence to the Practice Setting: A Diabetes Educator/Expert Prescriber Team Approach.
Bergen P, Kruger D, Taylor A, Eid W, Bhan A, Jackson J
Diabetes Educ. 2017; 43(3):311-323.
PMID: 28427304
PMC: 5439542.
DOI: 10.1177/0145721717701579.
Management of Diabetic Ketoacidosis in Severe Insulin Resistance.
Robinson C, Cochran E, Gorden P, Brown R
Diabetes Care. 2016; 39(8):e116-8.
PMID: 27271188
PMC: 4955933.
DOI: 10.2337/dc16-0635.
Treatment Approach to Patients With Severe Insulin Resistance.
Church T, Haines S
Clin Diabetes. 2016; 34(2):97-104.
PMID: 27092020
PMC: 4833480.
DOI: 10.2337/diaclin.34.2.97.
Mild Caloric Restriction Decreases Insulin Requirements in Patients With Type 2 Diabetes and Severe Insulin Resistance.
Meehan C, Cochran E, Mattingly M, Gorden P, Brown R
Medicine (Baltimore). 2015; 94(30):e1160.
PMID: 26222846
PMC: 4554137.
DOI: 10.1097/MD.0000000000001160.
Dosing of U-100 insulin and associated outcomes among Medicare enrollees with type 1 or type 2 diabetes.
Eby E, Van Brunt K, Brusko C, Curtis B, Lage M
Clin Interv Aging. 2015; 10:991-1001.
PMID: 26124652
PMC: 4476426.
DOI: 10.2147/CIA.S76398.
